MAKING PAIN
MEASURABLE
Building the first Class II FDA-cleared wearable for objective pain measurement for more accurate treatment.
OUR MISSION
Pain is the number one reason people seek medical care, but the tools guiding that care haven't changed in decades. NOCI exists to change that.
Meet the Team
1 in 4
Americans living with chronic pain
40-80%
Are misdiagnosed for years
$722.8B
The annual cost
The gold standard for pain care is still asking someone to pick a number between 0 - 10.
OBJECTIVE PAIN INTELLIGENCE FOR MORE ACCURATE TREATMENT
Clinical Grade Wearable
Continuous physiological monitoring
Patient app
Lived Experience of Pain
AI
Clinical interpretation
Objective Pain Intelligence
A structured, longitudinal pain signal for clinical decision-making.
Continuous physiology and lived experience become one signal for the first time.
TEAM
Built by engineers, clinicians, and scientists from Weill Cornell Medicine, Harvard, Pratt, Amazon, and Medtronic, with the expertise to take NOCI from prototype to FDA clearance.
Sushir Kadidal
CEO
Architect, industrial designer and product engineer. Has managed multi-million dollar projects from concept to delivery now applying that to clinical hardware.
Harry Sin
COO
10+ years scaling hardware manufacturing at Amazon and Medtronic. Leading clinical operations and production from prototype to FDA clearance.
Bobak Mosadegh
CSO
Professor of Biomedical Engineering at Weill Cornell. Our scientific foundation for sensor validation and FDA regulatory strategy.
ADVISORS
Dr. Rohan Jotwani, MD, MBA
Interventional Pain
Interventional Pain Specialist at Weill Cornell. Ensures everything we build maps to how pain care actually works.
JoAnn Difede, PhD
Clinical Trials
Director of Program for Anxiety and Traumatic Stress Studies (PATSS), Weill Cornell Medicine. Expert in clinical trial design with extensive NIH SBIR/STTR funding experience.
Alar Ainla, PhD
Bioelectronics
Researcher specializing in circuit design and sensor architecture for the wearable platform.
GET INVOLVED
CLINICIANS
Partner with us on early clinical validation.
INVESTORS
Back the first objective pain measurement platform. $1.2M pre-seed
Contact Us
NOCI
MAKING PAIN MEASURABLE
Noci Corporation. All Rights Reserved.
MAKING PAIN
MEASURABLE
Building the first Class II FDA-cleared wearable for objective pain measurement for more accurate treatment.
OUR MISSION
Pain is the number one reason people seek medical care, but the tools guiding that care haven't changed in decades. NOCI exists to change that.
Meet the Team
1 in 4
Americans living with chronic pain
40-80%
Are misdiagnosed for years
$722.8B
The annual cost
The gold standard for pain care is still asking someone to pick a number between 0 - 10.
OBJECTIVE PAIN INTELLIGENCE FOR MORE ACCURATE TREATMENT
Clinical Grade Wearable
Continuous physiological monitoring
Patient app
Lived Experience of Pain
AI
Clinical interpretation
Objective Pain Intelligence
A structured, longitudinal pain signal for clinical decision-making.
Continuous physiology and lived experience become one signal for the first time.
TEAM
Built by engineers, clinicians, and scientists from Weill Cornell Medicine, Harvard, Pratt, Amazon, and Medtronic, with the expertise to take NOCI from prototype to FDA clearance.
Sushir Kadidal
CEO
Architect, industrial designer and product engineer. Has managed multi-million dollar projects from concept to delivery now applying that to clinical hardware.
Harry Sin
COO
10+ years scaling hardware manufacturing at Amazon and Medtronic. Leading clinical operations and production from prototype to FDA clearance.
Bobak Mosadegh
CSO
Professor of Biomedical Engineering at Weill Cornell. Our scientific foundation for sensor validation and FDA regulatory strategy.
ADVISORS
Dr. Rohan Jotwani, MD, MBA
Interventional Pain
Interventional Pain Specialist at Weill Cornell. Ensures everything we build maps to how pain care actually works.
JoAnn Difede, PhD
Clinical Trials
Director of Program for Anxiety and Traumatic Stress Studies (PATSS), Weill Cornell Medicine. Expert in clinical trial design with extensive NIH SBIR/STTR funding experience.
Alar Ainla, PhD
Bioelectronics
Researcher specializing in circuit design and sensor architecture for the wearable platform.
GET INVOLVED
CLINICIANS
Partner with us on early clinical validation.
INVESTORS
Back the first objective pain measurement platform. $1.2M pre-seed
Contact Us
NOCI
MAKING PAIN MEASURABLE
Noci Corporation. All Rights Reserved.
MAKING PAIN
MEASURABLE
Building the first wearable platform for objective pain measurement.
Pursuing Class II FDA clearance.
OUR MISSION
Pain is the number one reason people seek medical care, but the tools guiding that care haven't changed in decades. NOCI exists to change that.
Meet the Team
1 in 4
Americans living with chronic pain
40-80%
Are misdiagnosed for years
$722.8B
The annual cost
The gold standard for pain care is still asking someone to pick a number between 0 - 10.
OBJECTIVE PAIN INTELLIGENCE FOR MORE ACCURATE TREATMENT
Clinical Grade Wearable
Continuous physiological monitoring
Patient app
Lived Experience of Pain
AI
Clinical interpretation
Objective Pain Intelligence
A structured, longitudinal pain signal for clinical decision-making.
Continuous physiology and lived experience become one signal for the first time.
TEAM
Built by engineers, clinicians, and scientists from Weill Cornell Medicine, Harvard, Pratt, Amazon, and Medtronic, with the expertise to take NOCI from prototype to FDA clearance.
Sushir Kadidal
CEO
Architect, industrial designer and product engineer. Has managed multi-million dollar projects from concept to delivery now applying that to clinical hardware.
Harry Sin
COO
Scaled regulated hardware manufacturing at Amazon and Medtronic. Knows the path from prototype to production.
Bobak Mosadegh
CSO
Professor of Biomedical Engineering at Weill Cornell. Our scientific foundation for sensor validation and FDA regulatory strategy.
ADVISORS
Dr. Rohan Jotwani, MD, MBA
Interventional Pain
Interventional Pain Specialist at Weill Cornell. Ensures everything we build maps to how pain care actually works.
JoAnn Difede, PhD
Clinical Trials
Director of Program for Anxiety and Traumatic Stress Studies (PATSS), Weill Cornell Medicine. Expert in clinical trial design with extensive NIH SBIR/STTR funding experience.
Alar Ainla, PhD
Bioelectronics
Researcher specializing in circuit design and sensor architecture for the wearable platform.
GET INVOLVED
CLINICIANS
Partner with us on early clinical validation.
INVESTORS
Back the first objective pain measurement platform. $1.2M pre-seed
Contact Us
NOCI
MAKING PAIN MEASURABLE
Noci Corporation. All Rights Reserved.